Read more about the article Cilcare steps up its U.S. expansion: Clinical trial at MGH, threefold capacity growth with CBSET, and launch of a gateway for foreign biotechs entering the American market
Panel at the SelectUSA investment Summit 2026

Cilcare steps up its U.S. expansion: Clinical trial at MGH, threefold capacity growth with CBSET, and launch of a gateway for foreign biotechs entering the American market

National Harbor, MD — May 5, 2026 — Cilcare, a French-US biopharmaceutical company specializing in auditory science, today announced a series of major investments in the United States at the…

Continue ReadingCilcare steps up its U.S. expansion: Clinical trial at MGH, threefold capacity growth with CBSET, and launch of a gateway for foreign biotechs entering the American market